MCM3AP and lung adenocarcinoma: As shown, MCM3AP-AS1 expression was up-regulated in both lung adenocarcinoma tissues (LUAD) and lung squamous carcinoma (LUSC) tissues; additionally, MCM3AP-AS1 overexpression was significantly linked to a shorter overall survival time of NSCLC patients (Figure 1a–b).